Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MRNA – Moderna, Inc.

Moderna, Inc.
MRNA
$27.61
Name : Moderna, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,740,553,728.00
EPSttm : -7.51
finviz dynamic chart for MRNA
Moderna, Inc.
$27.61
6.61%
$1.95

Float Short %

19.34

Margin Of Safety %

Put/Call OI Ratio

0.74

EPS Next Q Diff

0.64

EPS Last/This Y

-0.98

EPS This/Next Y

2.71

Price

27.6

Target Price

43.45

Analyst Recom

2.86

Performance Q

2.13

Relative Volume

1.49

Beta

1.83

Ticker: MRNA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04MRNA30.480.700.38898374
2025-07-07MRNA29.930.700.70856630
2025-07-08MRNA32.540.710.16864410
2025-07-09MRNA32.810.690.16897761
2025-07-10MRNA34.240.670.67925175
2025-07-11MRNA33.630.670.21945970
2025-07-14MRNA32.870.680.56928324
2025-07-15MRNA31.550.680.74943310
2025-07-16MRNA32.060.690.71948744
2025-07-17MRNA32.220.690.05961082
2025-07-18MRNA31.250.610.851040961
2025-07-21MRNA30.980.720.45840335
2025-07-22MRNA32.720.710.52859654
2025-07-23MRNA34.640.710.08870290
2025-07-24MRNA34.020.660.15910120
2025-07-25MRNA34.150.680.23902233
2025-07-28MRNA33.930.691.18859623
2025-07-29MRNA32.630.690.79869537
2025-07-30MRNA32.150.700.61874840
2025-07-31MRNA29.610.700.50877154
2025-08-01MRNA27.590.740.23884746
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04MRNA30.4910.4-895.9-10.10
2025-07-07MRNA29.9010.4-696.1-10.10
2025-07-08MRNA32.5410.4-1525.1-10.10
2025-07-09MRNA32.7910.4-898.9-10.10
2025-07-10MRNA34.2810.4-1170.6-10.10
2025-07-11MRNA33.6410.4-1029.9-10.10
2025-07-14MRNA32.8710.4-681.1-10.10
2025-07-15MRNA31.5810.4-561.4-10.10
2025-07-16MRNA32.0610.4-954.6-10.10
2025-07-17MRNA32.2010.4-874.9-10.10
2025-07-18MRNA31.2510.4-628.5-10.10
2025-07-21MRNA30.9810.4-776.5-10.10
2025-07-22MRNA32.7410.4-1271.3-10.10
2025-07-23MRNA34.6710.4-1270.9-10.10
2025-07-24MRNA34.019.4-711.5-10.26
2025-07-25MRNA34.159.4-872.5-10.26
2025-07-28MRNA33.899.6-790.2-10.26
2025-07-29MRNA32.669.6-583.9-10.26
2025-07-30MRNA32.1510.0-730.3-10.26
2025-07-31MRNA29.5610.0-254.9-10.26
2025-08-01MRNA27.6010.0-327.8-10.26
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04MRNA0.431.4718.56
2025-07-07MRNA0.431.4418.56
2025-07-08MRNA0.431.4418.56
2025-07-09MRNA0.431.4418.56
2025-07-10MRNA0.431.4418.56
2025-07-11MRNA0.431.4419.15
2025-07-14MRNA0.431.8619.15
2025-07-15MRNA0.431.8619.15
2025-07-16MRNA0.431.8619.15
2025-07-17MRNA0.431.8619.15
2025-07-18MRNA0.431.8619.15
2025-07-21MRNA0.431.7419.15
2025-07-22MRNA0.431.7419.15
2025-07-23MRNA0.431.7419.15
2025-07-24MRNA0.431.7419.15
2025-07-25MRNA0.431.7419.34
2025-07-28MRNA0.431.2019.34
2025-07-29MRNA0.431.2019.34
2025-07-30MRNA0.431.2019.34
2025-07-31MRNA0.431.2019.34
2025-08-01MRNA0.431.2019.34
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-2.52

Avg. EPS Est. Current Quarter

-2.95

Avg. EPS Est. Next Quarter

-1.88

Insider Transactions

0.43

Institutional Transactions

1.2

Beta

1.83

Average Sales Estimate Current Quarter

116

Average Sales Estimate Next Quarter

1149

Fair Value

Quality Score

40

Growth Score

36

Sentiment Score

2

Actual DrawDown %

94.5

Max Drawdown 5-Year %

-95.1

Target Price

43.45

P/E

Forward P/E

PEG

P/S

3.36

P/B

1.06

P/Free Cash Flow

EPS

-8.72

Average EPS Est. Cur. Y​

-10.26

EPS Next Y. (Est.)

-7.54

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-105.67

Relative Volume

1.49

Return on Equity vs Sector %

-57.1

Return on Equity vs Industry %

-38.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.15

EBIT Estimation

-327.8
Moderna, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 5800
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading